The U.S. Food and Drug Administration FDA will host an Industry Day on 6 December 2022 to discuss a Broad Agency Announcement (BAA) for state of the art advancements in technology, materials, processes, methods, devices, and techniques in pharmaceutical regulatory science. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and
The Association of Healthcare Emergency Preparedness Professionals will convene for the 2023 AHEPP Annual Conference in Scottsdale, AZ from March 1 & 2, 2023 and pre-conference on 28 February. This event is dedicated to advancing emergency preparedness in healthcare facilities, and specifically focuses on providing the latest research, education, and connections. Example topics and sessions include: Command,
The Third International Summit on Human Genome Editing will be held March 6-8, 2023 in London, UK. The event is being organized as a collaborative activity of the U.S. National Academy of Sciences and the U.S. National Academy of Medicine, the U.K.’s Royal Society and Academy of Medical Sciences, and The World Academy of Sciences. It
The Association of Schools and Programs of Public Health will convene the 2023 ASPPH Annual Meeting from 15-17 March 2023 in Arlington, Virginia. This event convenes academic public health leaders, faculty, students, and members of the public health community from around the world to engage in discussions and share new strategies and tools to strengthen
FDA and United States Pharmacopeia (USP) are cosponsoring the Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue. This program aims to accelerate APEC and global efforts to strengthen the resilience of global medical product supply chains. This meeting will bring international medical product regulators, multilateral organization representatives, and industry and academic professionals together, to
The U.S. Food and Drug Administration (FDA) is hosting a virtual public meeting 25 April 2023 on Patient-Focused Drug Development for Long COVID. This meeting will provide FDA the opportunity to obtain initial patient and patient representative input on the aspects of Long COVID, including how Long COVID affects their daily life, symptoms that matter
The U.S. Food and Drug Administration (FDA) will host a virtual town hall on 26 April 2023 for test developers to discuss the final guidances for the: Transition Plan for Medical Devices That Fall Within Enforcement Policies Issued During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency Transition Plan for Medical Devices Issued Emergency Use
The Biomedical Advanced Research and Development Authority (BARDA) and FDA will host a virtual workshop titled Recombinant Protein-Based COVID-19 Vaccines April 27, 2023, from 9:00 am EDT to 1:00 pm EDT. The goals of the workshop are to provide a forum for product sponsors to discuss progress and technical challenges in the manufacturing when changing
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual public listening meeting on 27 April 2023 to solicit input on methods and approaches (e.g., use of real-world evidence (RWE), registries) for capturing post approval safety and efficacy data for cell and gene therapy products. The rapid
